Loading...
Regencell Bioscience Holdings Limited
RGC•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$695.00
$70.05(11.21%)
Regencell Bioscience Holdings Limited (RGC) AI-Powered Stock Analysis
See how Regencell Bioscience Holdings Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerRegencell Bioscience Holdings Limited (RGC) Stock Overall Grade
Regencell Bioscience Holdings Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Regencell Bioscience Holdings Limited's overall stock rating.
Forecast
BScore
67/100Financial Growth
CScore
40/100Fundamental Growth
CScore
45/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Component Analysis Explained
Understand the key factors behind each Regencell Bioscience Holdings Limited stock grade, including financials, comparisons, and forecasts.